Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: D06BB10

Aldara(imiquimod)

Condylomata Acuminata;Keratosis;Keratosis, Actinic;Carcinoma, Basal Cell

Marketing Authorisation Holder: Viatris Healthcare Limited

EMA Authorisation: 18/09/1998

INN: imiquimod

Indication

Imiquimod cream is indicated for the topical treatment of : External genital and perianal warts (condylomata acuminata) in adults. Small superficial basal cell carcinomas (sBCCs) in adults. Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Aldara — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.